|
Market Closed -
Deutsche Boerse AG
02:04:53 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 25.30 EUR | 0.00% |
|
-1.17% | -15.10% |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 04-05 | Boiron SA announces Annual dividend, payable on June 05, 2026 | CI |
| Market Cap | 439M 510M 412M 376M 708M 48.72B 711M 4.89B 1.91B 24.59B 1.91B 1.87B 81.55B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 391M 454M 367M 335M 631M 43.41B 633M 4.35B 1.7B 21.91B 1.71B 1.67B 72.66B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
| 1 week | -1.17% | ||
| Current month | -5.95% | ||
| 1 month | -6.30% | ||
| 3 months | -8.33% | ||
| 6 months | -6.30% | ||
| Current year | -15.10% |
| 1 week | 25.3 | 26.2 | |
| 1 month | 25.3 | 27.4 | |
| Current year | 24.6 | 30.25 | |
| 1 year | 20.95 | 31.35 | |
| 3 years | 20.65 | 56.6 | |
| 5 years | 20.65 | 56.6 | |
| 10 years | 20.65 | 92.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 2024-12-31 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 2011-06-30 |
| Director/Board Member | 54 | 2010-03-09 | |
| Director/Board Member | 51 | 2013-05-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -1.17% | - | - | 510M | ||
| +0.02% | +1.36% | -13.16% | -7.68% | 13.26B | ||
| +0.53% | +2.99% | -31.39% | -55.80% | 4.99B | ||
| +0.27% | +1.59% | -5.32% | -4.34% | 4.66B | ||
| -0.43% | -1.64% | -1.22% | -30.17% | 4.02B | ||
| +0.08% | +3.06% | -20.99% | +4.77% | 3.59B | ||
| -0.67% | +2.71% | -2.98% | -4.10% | 3.43B | ||
| +0.47% | -0.53% | -9.87% | +7.51% | 3.31B | ||
| -2.19% | -2.26% | -22.25% | -13.02% | 2.38B | ||
| +0.74% | +2.97% | -26.78% | -14.44% | 1.72B | ||
| Average | -0.12% | +1.90% | -14.88% | -13.03% | 4.6B | |
| Weighted average by Cap. | -0.05% | +1.73% | -13.98% | -13.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 566M 457M 417M 786M 54.08B 789M 5.42B 2.12B 27.3B 2.12B 2.08B 90.51B | 501M 582M 470M 429M 808M 55.58B 811M 5.57B 2.17B 28.06B 2.18B 2.14B 93.03B |
| Net income | 11.34M 13.16M 10.63M 9.7M 18.28M 1.26B 18.34M 126M 49.2M 635M 49.39M 48.32M 2.1B | 32.64M 37.88M 30.61M 27.94M 52.63M 3.62B 52.8M 363M 142M 1.83B 142M 139M 6.06B |
| Net Debt | -49.74M -57.72M -46.63M -42.57M -80.2M -5.52B -80.45M -553M -216M -2.78B -217M -212M -9.23B | -47.86M -55.54M -44.87M -40.96M -77.16M -5.31B -77.41M -532M -208M -2.68B -209M -204M -8.88B |
Employees
2,499
Sector
Pharmaceuticals
| Date | Price | Change |
|---|---|---|
| 26-08-28 | €25.30 | 0.00% |
| 26-08-27 | €25.30 | -3.44% |
| 26-08-26 | €26.20 | +2.34% |
| 26-08-25 | €25.60 | -0.39% |
| 26-08-24 | €25.70 | +0.39% |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
- BON Stock
Select your edition
All financial news and data tailored to specific country editions
















